Ellen C. Zwarthoff - Concepedia

Author

Ellen C. Zwarthoff

Also Known As

Bianca Pollo, Chiara Calatozzolo, E C Zwarthoff, E ZWARTHOFF, E Zwarthoff, E. C. Zwarthoff, E. Zwarthoff, E.C. Zwarthoff, ELLEN C. ZWARTHOFF, Ellen C Zwarthoff

405

Publications

50K

Citations

H-Index

134

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Meertens Institute Erasmus MC Cancer Institute University of Regensburg

About

Ellen C. Zwarthoff is an author at Erasmus University Rotterdam specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	71	7.7K
2	Public Health	6	6	264
3	Engineering	5	5	1.6K
4	Health Sciences	3	3	158
5	Natural Sciences	2	2	176

Ellen C. Zwarthoff

150

Publications

13.6K

Citations

H-Index

Page 1

	Year	Citations
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy Roland Seiler, H.A.D.M. Ashab, Nicholas Erho, European Urology UrologyMolecular SubtypesGenitourinary CancerTumor HeterogeneityMedicine	2017	775
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, Cancer Cell UrologyGenitourinary CancerMedicineCancer GenomicsComprehensive Transcriptional Analysis	2016	633
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Jan A. Gossen, W J de Leeuw, C.H. Tan, Proceedings of the National Academy of Sciences EngineeringIn Vivo Gene TherapyTransgenic Mouse ModelsExperimental AnimalGenetics	1989	492
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer Sia V. Lindskrog, Frederik Prip, Philippe Lamy, Nature Communications	2021	353
Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome Bas W.G. van Rhijn, André N. Vis, Theodorus van der Kwast, Journal of Clinical Oncology	2003	319
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Bas W.G. van Rhijn, Irene Lurkin, François Radvanyi, PubMed Tumor BiologySurgical OncologyUrologyTumoral PathologyGenitourinary Cancer	2001	309
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy Lucie C. Kompier, Irene Lurkin, Madelon N.M. van der Aa, PLoS ONE	2010	305

Page 1